A
Anne H. Rowley
Researcher at Northwestern University
Publications - 136
Citations - 13125
Anne H. Rowley is an academic researcher from Northwestern University. The author has contributed to research in topics: Kawasaki disease & Pathogenesis. The author has an hindex of 46, co-authored 133 publications receiving 11368 citations. Previous affiliations of Anne H. Rowley include Loyola University Chicago & Children's Memorial Hospital.
Papers
More filters
Journal ArticleDOI
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.
Brian W. McCrindle,Anne H. Rowley,Jane W. Newburger,Jane C. Burns,Anne F. Bolger,Michael H. Gewitz,Annette L. Baker,Mary Anne Jackson,Masato Takahashi,Pinak B. Shah,Tohru Kobayashi,Mei-Hwan Wu,Tsutomu Saji,Elfriede Pahl +13 more
TL;DR: These recommendations provide updated and best evidence-based guidance to healthcare providers who diagnose and manage Kawasaki disease, but clinical decision making should be individualized to specific patient circumstances.
Journal ArticleDOI
Prevention of Infective Endocarditis Guidelines From the American Heart Association: A Guideline From the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group
Walter R. Wilson,Kathryn A. Taubert,Michael H. Gewitz,Peter B. Lockhart,Larry M. Baddour,Matthew E. Levison,Ann F. Bolger,Christopher H. Cabell,Masato Takahashi,Robert S. Baltimore,Jane W. Newburger,Brian L. Strom,Lloyd Y. Tani,Michael A. Gerber,Robert O. Bonow,Thomas J. Pallasch,Stanford T. Shulman,Anne H. Rowley,Jane C. Burns,Patricia Ferrieri,Timothy J. Gardner,David Goff,David T. Durack +22 more
TL;DR: In this article, the authors updated the recommendations by the American Heart Association (AHA) for the prevention of infective endocarditis that were last published in 1997, and the purpose of this statement is to update the recommendations.
Journal ArticleDOI
Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group.
Walter R. Wilson,Kathryn A. Taubert,Michael H. Gewitz,Peter B. Lockhart,Larry M. Baddour,Matthew E. Levison,Ann F. Bolger,Christopher H. Cabell,Masato Takahashi,Robert S. Baltimore,Jane W. Newburger,Brian L. Strom,Lloyd Y. Tani,Michael A. Gerber,Robert O. Bonow,Thomas J. Pallasch,Stanford T. Shulman,Anne H. Rowley,Jane C. Burns,Patricia Ferrieri,Timothy J. Gardner,David Goff,David T. Durack +22 more
TL;DR: The committee concluded that only an extremely small number of cases of IE might be prevented by antibiotic prophylaxis for dental procedures even if suchProphylactic therapy were 100 percent effective.
Journal ArticleDOI
Prevention of Rheumatic Fever and Diagnosis and Treatment of Acute Streptococcal Pharyngitis A Scientific Statement From the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics
Michael A. Gerber,Robert S. Baltimore,Charles B. Eaton,Michael H. Gewitz,Anne H. Rowley,Stanford T. Shulman,Kathryn A. Taubert +6 more
TL;DR: This report updates the 1995 statement by the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee and includes new recommendations for the diagnosis and treatment of GAS pharyngitis, as well as for the secondary prevention of rheumatic fever.
Journal ArticleDOI
Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease.
Chiea Chuen Khor,Chiea Chuen Khor,Sonia Davila,Sonia Davila,Willemijn B. Breunis,Yi-Ching Lee,Chisato Shimizu,Chisato Shimizu,Victoria J. Wright,Rae S. M. Yeung,Dennis E.K. Tan,Kar Seng Sim,Jie Jin Wang,Jie Jin Wang,Tien Yin Wong,Tien Yin Wong,Tien Yin Wong,Junxiong Pang,Junxiong Pang,Paul Mitchell,Rolando Cimaz,Nagib Dahdah,Yiu-fai Cheung,Guo Ying Huang,Wanling Yang,In Sook Park,Jong-Keuk Lee,Jer-Yuarn Wu,Michael Levin,Jane C. Burns,Jane C. Burns,David Burgner,David Burgner,Taco W. Kuijpers,Martin L. Hibberd,Martin L. Hibberd,Yu-Lung Lau,Jing Zhang,Xiao Jing Ma,Fang Liu,Lin Wu,Jeong Jin Yoo,Soo-Jong Hong,Kwi Joo Kim,Jae-Jung Kim,Young-Mi Park,Young Mi Hong,Sejung Sohn,Gi Young Jang,Kee Soo Ha,Hyo Kyoung Nam,Jung Hye Byeon,Sin Weon Yun,Myung Ki Han,Kyung-Yil Lee,Ja Young Hwang,Jung Woo Rhim,Min Seob Song,Hyoung Doo Lee,Dong Soo Kim,Jae Moo Lee,Jeng Sheng Chang,Fuu Jen Tsai,Chi Di Liang,Ming-Ren Chen,Hsin Chi,Nan Chang Chiu,Fu Yuan Huang,Luan-Yin Chang,Li-Min Huang,Ho-Chang Kuo,Kao Pin Huang,Meng Luen Lee,Betau Hwang,Yhu Chering Huang,Pi Chang Lee,Miranda Odam,Miranda Odam,Frank T. Christiansen,Campbell S. Witt,Paul N. Goldwater,Paul N. Goldwater,Nigel Curtis,Nigel Curtis,Pamela Palasanthiran,John B. Ziegler,Michael D. Nissen,Clare Nourse,Irene M. Kuipers,J Ottenkamp,Judy Geissler,Maarten H Biezeveld,Carline E. Tacke,Luc Filippini,Paul A. Brogan,Nigel Klein,Vanita Shah,M J Dillon,Robert Booy,Delane Shingadia,Anu Bose,Thomas Mukasa,Robert Tulloh,Colin Michie,Jane W. Newburger,Annette L. Baker,Anne H. Rowley,Stanford T. Shulman,Wilbert H. Mason,Masato Takahashi,Marian E. Melish,Adriana H. Tremoulet,Ananth C. Viswanathan,Elena Rochtchina,John Attia,Rodney J. Scott,Elizabeth G. Holliday,Stephen B. Harrap +117 more
TL;DR: The involvement of the FCGR2A locus may have implications for understanding immune activation in Kawasaki disease pathogenesis and the mechanism of response to intravenous immunoglobulin, the only proven therapy for this disease.